<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36430175</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>22</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13683</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232213683</ELocationID><Abstract><AbstractText>Post-COVID-19 syndrome (PCS) is characterized by persisting sequelae after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PCS can affect patients with all COVID-19 disease severities. As previous studies have revealed impaired blood flow as a provoking factor triggering PCS, it was the aim of the present study to investigate the potential association between self-reported chronic fatigue and retinal microcirculation in patients with PCS, potentially indicating an objective biomarker. A prospective study was performed, including 201 subjects: 173 patients with PCS and 28 controls. Retinal microcirculation was visualized by OCT angiography (OCT-A) and quantified using the Erlangen-Angio-Tool as macula and peripapillary vessel density (VD). Chronic fatigue (CF) was assessed according to the variables of Bell&#x2019;s score, age and gender. VDs in the superficial vascular plexus (SVP), intermediate capillary plexus (ICP) and deep capillary plexus (DCP) were analyzed, considering the repetitions (12 times). Seropositivity for autoantibodies targeting G protein-coupled receptors (GPCR-AAbs) was determined by an established cardiomyocyte bioassay. Taking account of the repetitions, a mixed model was performed to detect possible differences in the least square means between the different groups included in the analysis. An age effect in relation to VD was observed between patients and controls (p &lt; 0.0001). Gender analysis showed that women with PCS showed lower VD levels in the SVP compared to male patients (p = 0.0015). The PCS patients showed significantly lower VDs in the ICP as compared to the controls (p = 0.0001 (CI: 0.32; 1)). Moreover, considering PCS patients, the mixed model revealed a significant difference between those with chronic fatigue (CF) and those without CF with respect to VDs in the SVP (p = 0.0033 (CI: &#x2212;4.5; &#x2212;0.92)). The model included variables of age, gender and Bell&#x2019;s score, representing a subjective marker for CF. Consequently, retinal microcirculation might serve as an objective biomarker in subjectively reported chronic fatigue in patients with PCS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schlick</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6875-2466</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucio</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum M&#xfc;nchen-German Research Center for Environmental Health, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallukat</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Berlin Cures GmbH, 10719 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartsch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3250-3855</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skornia</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmanns</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szewczykowski</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schr&#xf6;der</LastName><ForeName>Thora</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raith</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogge</LastName><ForeName>Lennart</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heltmann</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moritz</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beitlich</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schottenhamml</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0258-2484</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine 3, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Immuntherapie (DZI), Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU) and Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6945-3241</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine 3, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Immuntherapie (DZI), Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU) and Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganslmayer</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine 1, Universit&#xe4;t of Erlangen-N&#xfc;rnberg, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruse</LastName><ForeName>Friedrich E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe4;mmer</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6294-0730</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mardin</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohberger</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2546-5504</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LGL; 2490-PC-2021-V14</GrantID><Agency>Bavarian Health and Food Safety Authority</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005451" MajorTopicYN="N">Fluorescein Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012171" MajorTopicYN="N">Retinal Vessels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">OCT angiography</Keyword><Keyword MajorTopicYN="N">chronic fatigue</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">functional GPCR autoantibodies</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">retinal microcirculation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest in relation to the topic of the present study. Hohberger B (Heidelberg Engineering), Gerd Wallukat (BerlinCures GmbH), Harrer T (none), Kruse F (none), Hoffmanns J (none), Rogge L (none), Heltmann F (none), Moritz M (none), Beitlich L (none), Lucio M (none), Schlick S (none), Schottenhamml J (none), L&#xe4;mmer R (none), Herrmann M (none), Mardin C (Heidelberg Engineering), Skornia A (none), Bartsch A (none).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36430175</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pii">ijms232213683</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation  Novel Coronavirus (2019-nCoV) Situation Report-1.  [(accessed on 18 February 2022)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4.</Citation></Reference><Reference><Citation>Wang M.Y., Zhao R., Gao L.J., Gao X.F., Wang D.P., Cao J.M. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front. Cell. Infect. Microbiol. 2020;10:587269. doi: 10.3389/fcimb.2020.587269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.587269</ArticleId><ArticleId IdType="pmc">PMC7723891</ArticleId><ArticleId IdType="pubmed">33324574</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzberger B., Buder F., Lampl B., Ehrenstein B., Hitzenbichler F., Holzmann T., Schmidt B., Hanses F. Epidemiology of SARS-CoV-2. Infection. 2021;49:233&#x2013;239. doi: 10.1007/s15010-020-01531-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01531-3</ArticleId><ArticleId IdType="pmc">PMC7543961</ArticleId><ArticleId IdType="pubmed">33034020</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  WHO Coronavirus (COVID-19) Dashbord.  [(accessed on 18 February 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schroder T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF online, Portal der wissenschaftlichen Medizin  S1-Leitlinie Post-COVID/Long-COVID. 2022.  [(accessed on 17 August 2022)].  Available online:  https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2022-08.pdf.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C., Rowe P.C., Visser F.C. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina. 2021;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of Antibody Immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson N.S., Jenkins G., Hart N. COVID-19 and what comes after?  [(accessed on 26 September 2022)];Thorax. 2021 76:324&#x2013;325. doi: 10.1136/thoraxjnl-2020-216226. Available online:  https://pubmed.ncbi.nlm.nih.gov/33589513/</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216226</ArticleId><ArticleId IdType="pubmed">33589513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenova N., Amital H., et al. COVID-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Hosari S., Wallukat G., Kunze R., Krebs J., Muller M., Hennig T., Lammer R., Horn F., Munoz L.E., et al. Agonistic autoantibodies against beta2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients. PLoS ONE. 2021;16:e0249202. doi: 10.1371/journal.pone.0249202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249202</ArticleId><ArticleId IdType="pmc">PMC8104926</ArticleId><ArticleId IdType="pubmed">33961631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukitsch I., Kehr J., Chaykovska L., Wallukat G., Nieminen-Kelha M., Batuman V., Dragun D., Gollasch M. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies. Transplantation. 2012;94:8&#x2013;13. doi: 10.1097/TP.0b013e3182529bb7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0b013e3182529bb7</ArticleId><ArticleId IdType="pubmed">22691955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Wollenberger A. Involvement of &#x3b2;2-Adrenergic Receptors in the Potentaion of the Chronotropic Action of Isoprenaline Evoked in Rocker-Cultured Neonatal Rat Heart Cells by Pyruvate and L (+) Lactate. Martinius Nijhoff Publishing; Boston, MA, USA: 1987.</Citation></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;Sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Mardin C.Y. OCT Angiography as an Interdisciplinary Diagnostic Tool for Systemic Diseases. Klin. Mon. Augenheilkd. 2021;238:1294&#x2013;1298. doi: 10.1055/a-1654-0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1654-0504</ArticleId><ArticleId IdType="pubmed">34879428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Lucio M., Schlick S., Wollborn A., Hosari S., Mardin C. OCT-angiography: Regional reduced macula microcirculation in ocular hypertensive and pre-perimetric glaucoma patients. PLoS ONE. 2021;16:e0246469. doi: 10.1371/journal.pone.0246469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246469</ArticleId><ArticleId IdType="pmc">PMC7877568</ArticleId><ArticleId IdType="pubmed">33571215</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carlo T.E., Romano A., Waheed N.K., Duker J.S. A review of optical coherence tomography angiography (OCTA) Int. J. Retin. Vitr. 2015;1:5. doi: 10.1186/s40942-015-0005-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40942-015-0005-8</ArticleId><ArticleId IdType="pmc">PMC5066513</ArticleId><ArticleId IdType="pubmed">27847598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Muller M., Hosari S., Mardin C.Y. OCT-Angiography: Mydriatic phenylephrine and tropicamide do not influence retinal microvasculature in macula and peripapillary region. PLoS ONE. 2019;14:e0221395. doi: 10.1371/journal.pone.0221395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221395</ArticleId><ArticleId IdType="pmc">PMC6797164</ArticleId><ArticleId IdType="pubmed">31622357</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G., Newcomb R., Cowl C.T., Murad M.H., Breeher L., Miller S., Trenary M., Neveau D., Higgins S. Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clin. Proc. 2021;96:1782&#x2013;1791. doi: 10.1016/j.mayocp.2021.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Park R., Chidharla A., Mehta K., Sun W., Wulff-Burchfield E., Kasi A. Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis. EClinicalMedicine. 2020;26:100519. doi: 10.1016/j.eclinm.2020.100519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100519</ArticleId><ArticleId IdType="pmc">PMC7445555</ArticleId><ArticleId IdType="pubmed">32864589</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Was ist Long COVID?&#x2014;Deutsche Gesellschaft f&#xfc;r ME/CFS. 2022.  [(accessed on 26 September 2022)].  Available online:  https://www.mecfs.de/longcovid.</Citation></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2020;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman K.J., Murovska M., Pheby D.F.H., Zalewski P. Our Evolving Understanding of ME/CFS. Medicina. 2021;57:200. doi: 10.3390/medicina57030200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030200</ArticleId><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;5:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;pfner N., Alberer M., Ankermann T., Bender S., Berner R., de Laffolie J., Dingemann J., Heinicke D., Haas J.P., Hufnagel M., et al. Recommendation for standardized medical care for children and adolescents with long COVID. Mon. Kinderheilkd. 2022;170:539&#x2013;547. doi: 10.1007/s00112-021-01408-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01408-1</ArticleId><ArticleId IdType="pmc">PMC9131710</ArticleId><ArticleId IdType="pubmed">35637934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Newton J., Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. 2013;2013:784520. doi: 10.1155/2013/784520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/784520</ArticleId><ArticleId IdType="pmc">PMC4045534</ArticleId><ArticleId IdType="pubmed">24959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhui K.S., Dinos S., Ashby D., Nazroo J., Wessely S., White P.D. Chronic fatigue syndrome in an ethnically diverse population: The influence of psychosocial adversity and physical inactivity. BMC Med. 2011;9:26. doi: 10.1186/1741-7015-9-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-26</ArticleId><ArticleId IdType="pmc">PMC3072345</ArticleId><ArticleId IdType="pubmed">21418640</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., Cotler J., Torres C., Johnson M., Mabie B. COVID-19 Symptoms Over Time: Comparing Long-Haulers to ME/CFS. Fatigue. 2021;9:59&#x2013;68. doi: 10.1080/21641846.2021.1922140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori A.C., Vance D.E., Slater L.Z., Crowe M. The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. J. Neurosci. Nurs. 2012;44:206&#x2013;217. doi: 10.1097/JNN.0b013e3182527690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JNN.0b013e3182527690</ArticleId><ArticleId IdType="pmc">PMC3390758</ArticleId><ArticleId IdType="pubmed">22743812</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblat J.D., Cha D.S., Mansur R.B., McIntyre R.S. Inflamed moods: A review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;53:23&#x2013;34. doi: 10.1016/j.pnpbp.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2014.01.013</ArticleId><ArticleId IdType="pubmed">24468642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonneville R., Klein I., de Broucker T., Wolff M. Post-infectious encephalitis in adults: Diagnosis and management. J. Infect. 2009;58:321&#x2013;328. doi: 10.1016/j.jinf.2009.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2009.02.011</ArticleId><ArticleId IdType="pmc">PMC7125543</ArticleId><ArticleId IdType="pubmed">19368974</ArticleId></ArticleIdList></Reference><Reference><Citation>Pont C., Ascaso F.J., Grzybowski A., Huerva V. Corneal endothelial cell density during diabetes mellitus and ocular diabetes complications treatment. J. Fr. Ophtalmol. 2020;43:794&#x2013;798. doi: 10.1016/j.jfo.2019.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfo.2019.12.003</ArticleId><ArticleId IdType="pubmed">32616318</ArticleId></ArticleIdList></Reference><Reference><Citation>Urrets-Zaval&#xed;a J.A., Esp&#xf3;sito E., Garay I., Monti R., Ruiz-Lascano A., Correa L., Serra H.M., Grzybowski A. The eye and the skin in endocrine metabolic diseases. Clin. Dermatol. 2016;34:151&#x2013;165. doi: 10.1016/j.clindermatol.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2015.12.001</ArticleId><ArticleId IdType="pubmed">26903183</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pinto R., Mul&#xe8; G., Vadal&#xe0; M., Carollo C., Cottone S., Agabiti Rosei C., De Ciuceis C., Rizzoni D., Ferri C., Muiesan M.L. Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies. Nutrients. 2022;14:2200. doi: 10.3390/nu14112200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112200</ArticleId><ArticleId IdType="pmc">PMC9182467</ArticleId><ArticleId IdType="pubmed">35683999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziedziak J., Zaleska-&#x17b;mijewska A., Szaflik J.P., Cudnoch-J&#x119;drzejewska A. Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy. Med. Sci. Monit. 2022;28:e935135. doi: 10.12659/MSM.935135.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.935135</ArticleId><ArticleId IdType="pmc">PMC8790937</ArticleId><ArticleId IdType="pubmed">35046380</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasiliou V., Thompson D.C., Smith C., Fujita M., Chen Y. Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells. Chem. Biol. Interact. 2013;202:2&#x2013;10. doi: 10.1016/j.cbi.2012.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2012.10.026</ArticleId><ArticleId IdType="pmc">PMC4128326</ArticleId><ArticleId IdType="pubmed">23159885</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., Guignabert C., Humbert M. Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)? Eur. Respir. J. 2020;56:2001634. doi: 10.1183/13993003.01634-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Lauritano D., Ronconi G., Calvisi V., Conti P. Antibodies for COVID-19-which, when and how long? J. Biol. Regul. Homeost. Agents. 2021;35:417&#x2013;422. doi: 10.23812/Theo_edit.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/Theo_edit</ArticleId><ArticleId IdType="pubmed">33896155</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim. Acta. 1987;46:S634&#x2013;S639.</Citation><ArticleIdList><ArticleId IdType="pubmed">2449194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel K., Schulze-Rothe S., Haberland A., M&#xfc;ller J., Wallukat G., Davideit H. Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy. Heliyon. 2017;3:e00362. doi: 10.1016/j.heliyon.2017.e00362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2017.e00362</ArticleId><ArticleId IdType="pmc">PMC5541141</ArticleId><ArticleId IdType="pubmed">28795160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Wenzel K., Schimke I. Analytics of Functional Autoantibodies in Patients with Chagas Disease. Methods Mol. Biol. 2019;1955:247&#x2013;261. doi: 10.1007/978-1-4939-9148-8_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9148-8_19</ArticleId><ArticleId IdType="pubmed">30868533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosari S., Hohberger B., Theelke L., Sari H., Lucio M., Mardin C.Y. OCT Angiography: Measurement of Retinal Macular Microvasculature with Spectralis II OCT Angiography&#x2014;Reliability and Reproducibility. Ophthalmologica. J. Int. D&#x2019;ophtalmologie. Int. J. Ophthalmol. Z. Augenheilkd. 2020;243:75&#x2013;84. doi: 10.1159/000502458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000502458</ArticleId><ArticleId IdType="pubmed">31509842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>